
Growth hormone zzso zzso decreases left zzso zzso zzso zzso zzso chamber zzso and promotes progression to zzso heart zzso It is, however, controversial, whether zzso replacement therapy in addition to standard medical heart failure therapy should be considered as routine treatment in zzso deficient patients with heart zzso In the present report of a zzso zzso deficient patient with heart failure, we demonstrate by using zzso zzso magnetic resonance imaging and zzso zzso zzso that even a 12 month period of zzso replacement therapy had no sustained effect on zzso or functional parameters of zzso performance nor on clinical signs or symptoms of heart zzso It is concluded that zzso replacement therapy should currently not be regarded as standard heart failure therapy in patients with zzso zzso and should only be employed under careful monitoring including close follow-up in a standardized zzso 

